Automation

PRODUCTS

  • Clean-in-Place / Sterilize-in-Place System

    The Powerfuge Pilot is a high-power, batch liquid/solid separation system for bacteria, yeast, proteins and sub-micron particles. It is the smallest member of the Powerfuge family of centrifuges. The Powerfuge Pilot system is a two-phase centrifuge that meets cGMP requirements as well as chemical and pharmaceutical industry protocols.

    • Bowl capacity: 1.1L
    • Flow rates up to 60 L/hr for batches up to 100 L
    • Dimensions ~ 35.6 cm wide x 56 cm deep x 56 cm high (14" x 22" x 22")
    • Total weight ~ 115 kg (253 lbs)
    • Fully scalable to larger automated P6, P12 and P18 models
    • Drier solids, clearer centrates
  • We have the expertise, technologies, and state-of-the-art facilities at ElevateBio BaseCamp® to deliver cell and gene therapies from concept through commercialization, all under a single roof, right from the start.

  • Accelerate your path to success with NetSuite by leveraging a top 3 NetSuite Partner in the world.

    5 star, award-winning support in your corner

    Optimize NetSuite for your industry, based on best practices, and get sound recommendations regarding processes and user scenarios based on years of expertise. We help our NetSuite clients and potential clients see what’s possible, set priorities, create a roadmap for accomplishment, and deliver results that matter.

    When you choose Sikich, you choose a dedicated team of NetSuite consultants who spent years in a specific industry before they joined us, and who are committed to making a vital contribution to your business.

    Get the connected, available and accountable support that your organization deserves by joining the ranks of our highly satisfied clients.

  • Streamline your Trial Master File (TMF) documentation and integrate with study sites to accelerate trial timelines.

    Other eTMFs promise ease of use and seamless integration with the sites eISF, but they can’t deliver 100% adoption.

  • Solutions for rapid response to vaccine development and manufacturing challenges

    Vaccine development trends emphasize the need for adaptability and accessible production facilities. Remote manufacturing tackles these challenges, facilitating decentralized vaccine production and rapid responses to health crises. Germfree, a leading cleanroom manufacturer, remains at the forefront of these trends by providing configurable solutions that satisfy regulatory requirements and end-user needs. By leveraging innovative remote manufacturing technologies, Germfree helps shape a more dynamic and efficient future for vaccine development and production.

WHITE PAPERS AND CASE STUDIES

NEWS